A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
Crossref DOI link: https://doi.org/10.1038/s41598-022-23726-4
Published Online: 2022-11-29
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Guo, Menglin
Shu, Yamin
Chen, Guosong
Li, Juan
Li, Feie
Text and Data Mining valid from 2022-11-29
Version of Record valid from 2022-11-29
Article History
Received: 7 July 2022
Accepted: 4 November 2022
First Online: 29 November 2022
Competing interests
: The authors declare no competing interests.